Nanjing Pharmaceutical Group Company Limited Class ASSE: 600713

"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 8, 2026 · Issued by Nanjing Pharmaceutical Group Company Limited Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Nanjing Pharmaceutical Group Company Limited Class A

"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Indicative Announcement on Suspension of Conversion of "NANJING PHARMACEUTICAL Convertible Bonds" During the Implementation of Interim Dividend Distribution for 2026Sep 4
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Temporarily Idle Raised Funds and Continued Cash Management by the CompanySep 3
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Issuance Results of the 11th Tranche of Super Short-term Commercial Paper for 2026Aug 29
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on the Departure of a Non-Independent DirectorAug 22

All Nanjing Pharmaceutical Group Company Limited Class A news releases